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Abstract Plexins are receptors for the repulsive axon guidance
molecules semaphorins. Previously, we have shown that plexin-
B1 binds activated Rac, but that clustering of plexin-B1 causes
Rho activation, resulting in stress ¢ber formation. Using the
yeast two-hybrid system, we found that the C-terminus of B
plexins interacted directly with Rho-speci¢c exchange factors,
via their PDZ domain. Mutation of the carboxy-terminal amino
acids of plexin-B1 or coexpression of a dominant negative PDZ-
RhoGEF abrogated the ability of plexin-B1 to cause stress ¢ber
formation. Our results demonstrate a role for PDZ-RhoGEF in
B plexin-mediated activation of Rho/Rho kinase signaling, im-
plicated in the regulation of axon guidance and cell migration.
+ 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Signaling pathways that link extracellular factors to activa-
tion of Rho GTPases control cytoskeletal rearrangements and
cell growth [1]. Rho regulates the assembly of contractile ac-
tin-myosin ¢laments [2], Rac induces actin polymerization to
produce lamellipodia [3], while Cdc42 induces actin assembly
leading to ¢lopodia [4,5]. Guanine nucleotide exchange factors
(GEFs) promote the exchange of GDP for GTP, thus activat-
ing Rho-like proteins [6], whereas GTPase-activating proteins
increase the low intrinsic rate of GTP hydrolysis of small
GTPases and are negative regulators [1]. In their active,
GTP-bound state Rho-like GTPases interact with and activate
e¡ectors, amongst which protein or lipid kinases and sca¡old
proteins [7]. GEFs possess a tandem Dbl homology (DH) and
pleckstrin homology (PH) domain that catalyzes the GDP^
GTP exchange reaction of speci¢c Rho proteins. Moreover,
GEFs may contain a variety of other domains, which allow
them to participate in di¡erent signaling processes [7].
Plexin-B1 is a semaphorin receptor [8], which signals to-
wards Rho proteins [9]. Since plexins and semaphorins are
widely expressed they are likely to have a variety of biological
functions. Their best characterized role to date is in axonal
growth cone guidance (for review [10,11]). The secreted sem-
aphorin Sema3A inhibits neurite outgrowth and induces the
collapse of lamellipodia and ¢lopodia in growth cones
[8,11,12]. Sema4D is a membrane-bound ligand for plexin-
B1 that appears to be involved in adhesion and proliferation
of lymphocytes [8,13,14]. Previously, we and others have
found that plexins signal directly to di¡erent Rho GTPases
[9,15,16]. Plexin-B1 interacts directly with Rac in its active
GTP-bound state. However, clustering of plexin-B1 caused
formation of stress ¢bers via Rho, suggesting that plexin-B1
activates Rho and not Rac [9]. Here we present evidence that
plexin-B1 activates Rho via PSD-95/Dlg/ZO-1 (PDZ)-Rho-
GEF, an activator of Rho also implicated in G protein-
coupled receptor signaling towards Rho via GK12 and/or 13
[17^21].
2. Materials and methods
2.1. Vectors
The expression vectors for CD2/plexin-B1 [9], for myc-tagged PDZ-
RhoGEF [18], for FLAG-tagged PDZ-RhoGEF [22], for VSV-tagged
plexin-B1 [8] and VSV-tagged DCC [8] have been described before.
The yeast bait vectors pYTH or pGBT9 containing PDZ-Rho-
GEFvDH amino acids 1^1522, except for a deletion of amino acids
735^958); PDZ (amino acids 1^300); DH/PH (amino acids 735^
1120); DH (amino acids 735^958); regulator of G protein signaling
(RGS) (amino acids 301^592) and C1 (amino acids 1121^1522) or the
PDZ domain of LARG (amino acids 1^182) and the yeast prey vec-
tors pACTII containing plexin-B1, plexin-B1v3aa, B2, A2 or D1 cy-
toplasmic domain were generated by PCR. In PDZ-RhoGEF-RGSm/
vDH amino acids I364L, W365G in the RGS domain were mutated
by site-directed mutagenesis.
2.2. Yeast two-hybrid analysis
A human brain cDNA library fused to the GAL-4 activation do-
main in the pACTII vector was screened using PDZ-RhoGEFvDH
fused to the GAL-4 DNA binding domain in pYTH9 vector as a bait
[23]. Approximately 6U106 yeast colonies were screened for their
ability to grow on selective medium containing 25 mM 3-aminotria-
zole. Plasmids were rescued from 12 L-galactosidase positive clones
and sequence analysis showed that they encoded six di¡erent cDNAs.
One plasmid encoded the last 106 amino acids of plexin-B1.
2.3. Co-immunoprecipitation assay
HEK293 cells were transfected by calcium phosphate coprecipita-
tion and lysed after 20 h of culture in lysis bu¡er (1% Nonidet P-40,
150 mM NaCl, 50 mM Tris, pH 8.0 containing protease inhibitors)
for 30 min. Cleared lysates were incubated with anti-VSV antibodies
and proteins were precipitated using protein G Sepharose. After three
washes proteins were eluted with SDS sample bu¡er, separated by
SDS^PAGE, blotted onto polyvinylidene di£uoride membrane and
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revealed with anti-FLAG (M2 monoclonal antibody (mAb), Sigma)
or anti-VSV antibodies.
2.4. CD2/plexin-B1 chimera crosslinking assay
Microinjection of serum-starved, quiescent Swiss 3T3 cells, the
crosslinking and staining procedure have been described before [9].
Brie£y, nuclei of 100 cells were injected with an expression vector
containing CD2/plexin-B1 or CD2/plexin-B1-FLAG at a concentra-
tion of 0.1 mg/ml. After 5 h incubation, membrane-localized CD2
proteins were crosslinked using the OX34 mouse anti-rat CD2
mAb, followed by donkey anti-mouse IgG for 15 min at 37‡C. Cells
were ¢xed with 4% paraformaldehyde. CD2-positive cells were iden-
ti¢ed using the OX34 mAb, followed by goat anti-mouse FITC (Jack-
son Immunoresearch), actin was stained using rhodamine-phalloidin
and myc-positive cells were identi¢ed using rat anti-myc Jac6 mAb
(Serotech), followed by goat anti-rat TR (Jackson Immunoresearch).
For double staining for CD2 and myc, ¢rst the CD2 staining was
completed, the sample was blocked using mouse IgG and then stained
for myc. Coverslips were mounted in Moviol and scored on a Zeiss
Axiophot microscope with 40U and 63U oil immersion lenses. Fluo-
rescent images were recorded on a confocal microscope (Zeiss).
3. Results
3.1. PDZ-RhoGEF binds to the C-terminus of B plexins in
yeast two-hybrid analysis
Previously, we and others have shown that PDZ-RhoGEF,
also know as kiaa0380, is a Rho-speci¢c GEF, which causes
cell rounding upon microinjection into Swiss 3T3 cells
[17,18,21]. To identify proteins that interact with PDZ-Rho-
GEF we performed a yeast two-hybrid screen with a human
brain cDNA library and a deletion mutant of PDZ-RhoGEF,
missing the DH domain, as bait. Sequence analysis of a plas-
mid rescued from yeast clones showed complete sequence
identity to the C-terminal 106 amino acids (residues 2031^
2135) of the cytoplasmic domain of human plexin-B1, a trans-
membrane receptor for semaphorins [8] (Fig. 1A).
To map the domain by which PDZ-RhoGEF interacts with
plexin-B1, the separate domains were tested in yeast two-hy-
brid analysis. As shown in Fig. 1A, plexin-B1 binds to the
PDZ domain of PDZ-RhoGEF. PDZ domains bind speci¢c
recognition sequences, such as (S/T)-X-(V/I/L), at the car-
boxy-termini of certain proteins [24]. Four classes of plexins
(A, B, C and D) have been described [8]. Examination of the
carboxy-termini showed that all B plexins contain a class I
consensus sequence for PDZ binding (TDL). Therefore, we
tested whether other plexins interacted with the PDZ domain
of PDZ-RhoGEF in yeast two-hybrid analysis. As shown in
Fig. 1B, plexin-B1 and -B2 interacted with the RhoGEF PDZ
domain, whereas plexin-A2 or plexin-D1 did not. No interac-
tion of the plexins was found with the RGS domain of PDZ-
RhoGEF or the empty pACTII vector (not shown). Mutation
of the putative PDZ binding sequence in the plexin-B1 C-ter-
minus by deleting the last three amino acids abrogates the
interaction between plexin-B1 and the PDZ domain, indicat-
ing a direct interaction between the PDZ domain and the
PDZ binding motif in the plexin-B1 C-terminus. Plexin-B1
and -B2 interacted as well with the PDZ domain of LARG
(Fig. 1C), another Rho-speci¢c GEF very similar to PDZ-
RhoGEF [25].
3.2. PDZ-RhoGEF is implicated in Rho activation by plexin-B1
clustering in Swiss 3T3 ¢broblasts
Plexins are receptors for semaphorins and regulate axon
guidance and cell migration [10]. Previously, we have shown
that clustering of a CD2/plexin-B1 chimera in quiescent Swiss
3T3 cells caused formation of actin bundles and cell contrac-
tion, by activation of Rho [9]. Therefore, we used the plexin
clustering assay to investigate the e¡ect of mutating the PDZ
binding sequence in the plexin-B1 C-terminus.
As shown in Fig. 2A, plexin-B1 clustering caused formation
of actin bundles and plexin clusters were found to be concen-
trated where the actin bundles form apical constrictions. In
contrast, clustering of a mutant plexin-B1 chimera in which
the last leucine amino acid was replaced with a FLAG tag
(CD2/plexin-B1-FLAG) did not cause formation of stress ¢-
bers (Fig. 2B). We conclude that Rho activation is mediated
via the plexin-B1 C-terminus, by binding and activation of a
PDZ domain containing RhoGEF. To substantiate this con-
clusion, we coexpressed the CD2/plexin-B1 chimera with a
myc-tagged full length PDZ-RhoGEF in Swiss 3T3 cells.
PDZ-RhoGEF when overexpressed in Swiss 3T3 cells causes
cortical actin reorganization and cell rounding [18]. It is lo-
calized at the plasmamembrane and a proline-rich motif ad-
jacent to the DH/PH module is essential for the ability of
PDZ-RhoGEF to cause this cell rounding [18]. As shown in
Fig. 2C, upon crosslinking of CD2-plexin-B1 clear colocaliza-
tion was observed with myc-PDZ-RhoGEF in the cell cortex
at the area of cell^substrate contact, suggesting that PDZ-
RhoGEF interacts with plexin-B1 in Swiss 3T3 cells.
To determine if B plexins interact with PDZ-RhoGEF in
vivo, we overexpressed VSV-tagged plexin-B1 and FLAG-
tagged full length PDZ-RhoGEF in HEK293 cells and per-
formed a co-immunoprecipitation assay. When VSV-plexin-
B1 was precipitated from lysates with the VSV antibody, the
Fig. 1. Interaction between B plexins and PDZ-RhoGEF. A: PDZ-
RhoGEF binds to the C-terminus of plexin-B1 via its PDZ domain.
Yeast strains containing the indicated domains of PDZ-RhoGEF in
the integrated bait vector pYTH were transformed with the pACTII
prey vector containing the plexin-B1 C-terminus (amino acids 2031^
2153) and plated on minus Leu, minus Trp plates as described [23].
Colonies of equal size were replated in the presence of 3-aminotri-
azole on minus Leu, minus Trp, minus His, minus Ura plates and
allowed to grow for 3 days. B: The PDZ domain of RhoGEF binds
to B plexins. Yeast strains were cotransformed with the pGBT9 bait
vector containing the PDZ-RhoGEF PDZ domain (amino acids 1^
300) and the prey vectors pACTII containing plexin-B1 C-terminus
(amino acids 1724^end, plexin-B2 C-terminus (amino acids 1441^
end), plexin-A2 (amino acids 1544^end and plexin-D1 (amino acids
1591^end), plexin-B1v3aa (amino acids 1724^2132, the last three
amino acids have been deleted). C: The PDZ domain of LARG
binds to B plexins. Yeast strains were cotransformed with the
pGBT9 bait vector containing the LARG PDZ domain (amino
acids 1^182) and the prey vectors as described in B.
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FLAG-PDZ-RhoGEF was co-immunoprecipitated with the
plexin-B1 (Fig. 3). FLAG-PDZ-RhoGEF was not co-immu-
noprecipitated with VSV-DCC. This suggests that PDZ-Rho-
GEF interacts with and forms a complex with plexin-B1 in
vivo.
PDZ-RhoGEF also plays a role in signaling from G pro-
tein-coupled receptors and GK12/13 proteins to Rho. The
RGS domain of PDZ-RhoGEF inhibits stress ¢ber formation
induced by lysophosphatidic acid (LPA) [21]. Previously, we
showed that overexpression of the N-terminal fragment of
Fig. 2. The e¡ects of crosslinking of a chimeric CD2/plexin-B1 on
the actin cytoskeleton. Quiescent Swiss 3T3 cells were injected with
an expression vector containing CD2/plexin-B1 (A, a^c) or CD2/
plexin-B1-FLAG (B, d^f) or CD2/plexin-B1 was coinjected with
myc-tagged PDZ-RhoGEF (C, g^i). After 5 h incubation, mem-
brane-localized CD2 proteins were crosslinked using the OX34
mouse anti-rat CD2 and donkey anti-mouse IgG for 15 min. CD2
expression (a,d,g), F-actin organization (b,e) and myc (h) expression
are shown. Images c,f,i are the merged images. D: Mutation of the
plexin-B1 C-terminus or coexpression of dominant negative PDZ-
RhoGEF constructs abrogates stress ¢ber formation upon CD2/
plexin-B1 crosslinking. Quiescent Swiss 3T3 cells were injected with
CD2/plexin-B1, CD2/plexin-B1-FLAG in which the last leucine of
the plexin-B1 C-terminus had been replaced by a FLAG tag or
CD2/plexin-B1 was co-injected with PDZ-RhoGEF/vDH or PDZ-
RhoGEF-RGSm/vDH plasmids. Five hours later CD2 proteins
were crosslinked and F-actin was stained. The % of CD2-positive
cells containing actin stress ¢bers was counted. Results are given as
mean+S.D. of three to ¢ve experiments.
Fig. 3. Interaction of VSV-tagged plexin-B1 with FLAG-tagged
PDZ-RhoGEF in vivo. HEK293 cells were cotransfected with VSV-
tagged DCC or VSV-tagged plexin-B1 and FLAG-tagged PDZ-Rho-
GEF. Lysates were incubated with anti-VSV antibody and immuno-
complexes were precipitated and subjected to immunoblot analysis
with anti-FLAG antibody (A) or anti-VSV antibody (B) In A clear
co-immunoprecipitation of FLAG-PDZ-RhoGEF is observed with
plexin-B1 (arrow) but not with DCC. In C, it is shown that FLAG-
PDZ-RhoGEF is well expressed in the cell lysates.
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PDZ-RhoGEF (amino acids 1^592), containing the RGS do-
main, was able to inhibit LPA-induced neurite retraction in
Neuro2a cells [18]. Therefore, we studied the e¡ect of a PDZ-
RhoGEF, in which the Dbl homology domain was removed,
in Swiss 3T3 cells.
As shown in Fig. 4a, dominant negative PDZ-RhoGEF
blocks cell contraction induced by sphingosine-1-phosphate
(S1P), a potent activator of Rho, in Swiss 3T3 cells. Interest-
ingly, a RGSm/vDH double mutant PDZ-RhoGEF, contain-
ing mutations in the RGS domain preventing interaction with
GK12/13 proteins, did not block the induction of cell round-
ing by S1P (Fig. 4b). This shows that S1P activates Rho via G
protein-coupled receptors involving G12/13 proteins in Swiss
3T3 cells, as shown before for other cell types [26,27]. Co-
injection of the dominant negative PDZ-RhoGEF or the
RGSm/vDH double mutant inhibits the formation of stress
¢bers by clustering of CD2-plexin-B1, suggesting that an en-
dogenous PDZ-RhoGEF in Swiss 3T3 cells mediates the stress
¢ber formation (Fig. 2D).
4. Discussion
We report here that the C-terminus of human plexin-B1 or
-B2 interacts with the PDZ domain of PDZ-RhoGEF and
LARG. The human plexin-B subfamily includes one addition-
al member, plexin-B3, and since the C-terminal amino acids
are completely conserved it is likely that plexin-B3 will inter-
act with the PDZ domains as well. Northern blot analysis
reveals that plexin-B1 is widely expressed in fetal and adult
tissues such as brain, lung, liver and kidney, and in neural,
hematopoietic and endothelial cells [28]. PDZ-RhoGEF is
highly expressed in brain, testis, heart, ovary and placenta
and to a lower level in kidney, pancreas, spleen, prostate,
colon, skeletal muscle, lung and liver [17]. LARG is expressed
in spleen, prostate, testis, ovary, small intestine and colon,
peripheral blood lymphocytes and to a low level in the thymus
[25]. The role of B plexins in vivo is unclear at the moment,
but as plexin-B1 and the PDZ-containing RhoGEFs are coex-
pressed in several tissues, it is likely that the interactions play
an important role in plexin-B-mediated signaling. During sub-
mission of this article a paper by Swiercz et al. was published,
in which the authors show that plexin-B1 interacts with PDZ-
RhoGEF and LARG in brain and that this interaction is of
functional importance in mediating growth cone collapse of
hippocampal neurons stimulated by Sema4D, the plexin-B1
ligand [22].
In Fig. 5, we present a model for activation of Rho by
PDZ-RhoGEF. Ligand binding to G protein-coupled recep-
tors activates PDZ-RhoGEF by binding of GK13 to the RGS
domain [6,17,18,21,26,27]. We now present evidence for a sec-
ond activating input signal on PDZ-RhoGEF, namely binding
of plexins to the PDZ domain of PDZ-RhoGEF. Sema4D, a
ligand for plexin-B1, forms homodimers and dimerization of
Sema3A is required to induce growth cone collapse [11,13]. It
seems likely, therefore, that semaphorins induce receptor ac-
tivation through clustering. Clustering of plexin-B1 presum-
ably activates PDZ-RhoGEF or LARG leading to Rho acti-
vation and the formation of stress ¢bers (see Fig. 5). The
exact mechanism of activation is unclear, but it might be
similar to that of the insulin-like growth factor-1 (IGF-1)
receptor, which directly interacts with LARG through the
PDZ domain [29]. Similar as the interaction of LARG with
the IGF-1 receptor, the interaction of PDZ-RhoGEF with
plexin-B1 is observed in the absence of ligand, suggesting
that the interaction is constitutive [29]. Physiological activa-
tion of the RhoGEF by ligand binding to the receptor is likely
to induce full activation of the RhoGEF and G proteins
[17,19,29] or phosphorylation of the GEF by kinases like
FAK [30] could be involved.
In Drosophila, DRhoGEF2, the £y orthologue of PDZ-
RhoGEF, LARG and p115RhoGEF, mediates cell shape
changes during gastrulation [31,32]. Flies possess two plexins,
plexin-A and -B. Genetic evidence suggests that plexin-B me-
diates axon repulsion in vivo by downregulating Rac and by
activating Rho [33]. It will be of interest to determine whether
DRhoGEF2 functions downstream of plexins in regulation of
axon guidance in Drosophila.
Several extracellular signaling molecules like ephrin-A5,
thrombin or LPA cause collapse of the growth cone by acti-
vating Rho [34^36]. Interestingly, Sema3A requires active Rac
to induce growth cone collapse and Rho kinase inhibitors do
not block its ability to cause collapse [12,37]. This suggests
that Rho activation is not part of the mechanism causing
growth cone collapse by Sema3A. In future experiments we
Fig. 4. Dominant negative myc-tagged PDZ-RhoGEF/vDH (a) but
not the double mutant PDZ-RhoGEF-RGSm/vDH (b) blocks cell
contraction induced by S1P. Swiss 3T3 cells were microinjected with
myc-tagged constructs, left to express for 3 h and then treated with
5 WM S1P for 15 min. Cells were ¢xed and stained as described.
Shown is a confocal image (myc staining in green and actin staining
using rhodamine phalloidin in red).
Fig. 5. Proposed mechanism whereby plexins and G protein-coupled
receptors stimulate Rho-dependent pathways. Ligand binding of
semaphorin to plexins causes activation of PDZ-RhoGEF via its
PDZ domain, thereby stimulating the exchange of GDP for GTP
on Rho, through its DH and PH domains. A parallel input on
PDZ-RhoGEF is established by ligand binding to G protein-coupled
receptors activating GK13, which interacts with PDZ-RhoGEF
through its RGS domain, thus catalyzing the exchange of GDP for
GTP on Rho.
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aim to investigate whether B plexins and PDZ-RhoGEF are
involved in axon guidance and cell migration.
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